Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-like peptide-1 receptor agonist use in pregnancy: a review
Rosa F Drummond, Karl Seif, E. Albert Reece
American Journal of Obstetrics and Gynecology (2024) Vol. 232, Iss. 1, pp. 17-25
Closed Access | Times Cited: 12

Showing 12 citing articles:

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025) Vol. 14, pp. 100164-100164
Open Access | Times Cited: 2
Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review
Sarah Price, Alison Nankervis
Archives of Gynecology and Obstetrics (2025)
Open Access | Times Cited: 1
GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence
Maria S. Varughese, Fidelma O’Mahony, Lakshminarayanan Varadhan
Clinical Medicine (2025), pp. 100298-100298
Open Access | Times Cited: 1
Optimizing Diabetes-in-Pregnancy Outcomes Requires a Care Continuum
Andy Huang, Menachem Miodovnik, E. Albert Reece
American Journal of Perinatology (2025)
Closed Access
Indeed, safety comes first for the use of GLP‐1RAs
Amruta D. S. Pathare, Alberto Sola‐Leyva, Apostol Apostolov, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2025)
Open Access
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
Paulo César Gete Palacios, Alberto Moscona-Nissan, Renata Saucedo, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 260-260
Open Access
Medical Management of Obesity: Current Trends and Future Perspectives
Andrés Calderón, Maria Aguilera Astudillo, Alexsandra P. Rojas, et al.
Methodist DeBakey Cardiovascular Journal (2025) Vol. 21, Iss. 2, pp. 62-73
Closed Access
Pregnancy Outcomes After Semaglutide Exposure
Line Kolding, Jakob Nørgaard Henriksen, Eva Aggerholm Sædder, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 4
Open Access
Teratogenic risks of treated and untreated maternal obesity
Robert E. Jones, Chloe Zera
Seminars in Perinatology (2025), pp. 152081-152081
Closed Access
GLP-1 and its analogues: Does sex matter?
Stina Börchers, Karolina P. Skibicka
Endocrinology (2024)
Open Access | Times Cited: 3
Epigenetic inheritance of PCOS by developmental programming and germline transmission
Elisabet Stener‐Victorin, Qiaolin Deng
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 2
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
C.E. Cesta, Ran S. Rotem, B.T. Bateman, et al.
Obstetric Anesthesia Digest (2024) Vol. 44, Iss. 4, pp. 200-201
Open Access | Times Cited: 1
Page 1

Scroll to top